Wallach Summit Lifedop Doppler Probe for L150 L250 Systems

The Wallach Summit Lifedop EchoHeart Probe is the first-ever transvaginal audio Doppler probe, engineered to detect fetal viability earlier than conventional Dopplers—as early as 6 weeks of pregnancy. Designed for use with the Wallach Summit L150 and L250 Doppler systems, this advanced probe offers unmatched sensitivity and performance in early obstetrical assessments.

Unlike standard Doppler probes, the EchoHeart is shaped and positioned similarly to transvaginal ultrasound imaging probes, allowing clinicians to obtain accurate, early fetal heartbeat detection with no special training required. This makes it a practical and cost-effective solution for practices that frequently evaluate high-risk pregnancies, retroverted uteruses, or patients with higher BMI, where early detection can be more challenging.

Because conventional Dopplers often cannot detect fetal heartbeat this early, the EchoHeart provides a reliable in-office solution that reduces the need for immediate imaging referrals, improving workflow and enhancing patient experience. In a clinical study, practitioners detected fetal heartbeats in 71% of patients between 6 and 8 weeks using EchoHeart.

The probe is designed for seamless integration with Summit Doppler systems, allowing quick interchangeability with existing 2 MHz and 3 MHz probes. (Note: Not compatible with Dopplers from other manufacturers.)

Whether used for early viability checks, multiple monitoring visits, or specialized cases, the EchoHeart probe offers powerful early diagnostic capabilities while maximizing your equipment investment.

🔵 KEY FEATURES

• First transvaginal audio Doppler probe for early fetal viability evaluation

• Detects fetal heartbeat as early as 6 weeks

• Ideal for high-risk pregnancies, retroverted uterus, and obese patients

• Similar in shape and positioning to transvaginal imaging probes—no special training required

• Reduces need for immediate imaging and costly follow-up exams

• Interchangeable with Summit 2 MHz and 3 MHz probes

• Compatible with Wallach Summit L150 and L250 Doppler systems only

• Provides fast, economical in-office viability confirmation

• Clinical detection success rate: 71% between 6–8 weeks

• Enhances practice efficiency and patient reassurance